Literature DB >> 32373650

Movement Disorders in the World of COVID-19.

A Jon Stoessl1, Kailash P Bhatia2, Marcelo Merello3.   

Abstract

Entities:  

Year:  2020        PMID： 32373650      PMCID： PMC7197302          DOI： 10.1002/mdc3.12952

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  6 in total

1.  Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system.

Authors:  Marc F Doobay; Lauren S Talman; Teresa D Obr; Xin Tian; Robin L Davisson; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-31       Impact factor: 3.619

2.  Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2.

Authors:  Jason Netland; David K Meyerholz; Steven Moore; Martin Cassell; Stanley Perlman
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

3.  Synergistic effects of influenza and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) can be eliminated by the use of influenza therapeutics: experimental evidence for the multi-hit hypothesis.

Authors:  Shankar Sadasivan; Bridgett Sharp; Stacey Schultz-Cherry; Richard Jay Smeyne
Journal:  NPJ Parkinsons Dis       Date:  2017-05-23

Review 4.  The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.

Authors:  Yan-Chao Li; Wan-Zhu Bai; Tsutomu Hashikawa
Journal:  J Med Virol       Date:  2020-03-11       Impact factor: 2.327

5.  Conductance and amantadine binding of a pore formed by a lysine-flanked transmembrane domain of SARS coronavirus envelope protein.

Authors:  Jaume Torres; Uma Maheswari; Krupakar Parthasarathy; Lifang Ng; Ding Xiang Liu; Xiandi Gong
Journal:  Protein Sci       Date:  2007-09       Impact factor: 6.725

6.  The substantia nigra is a major target for neurovirulent influenza A virus.

Authors:  M Takahashi; T Yamada; S Nakajima; K Nakajima; T Yamamoto; H Okada
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307
  6 in total
  8 in total

Review 1.  COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.

Authors:  David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2020-08-20

2.  Correlates of Psychological Distress in Patients with Parkinson's Disease During the COVID-19 Outbreak.

Authors:  Rosa De Micco; Mattia Siciliano; Valeria Sant'Elia; Alfonso Giordano; Antonio Russo; Gioacchino Tedeschi; Alessandro Tessitore
Journal:  Mov Disord Clin Pract       Date:  2020-11-13

Review 3.  Internet of things (IoT) applications to fight against COVID-19 pandemic.

Authors:  Ravi Pratap Singh; Mohd Javaid; Abid Haleem; Rajiv Suman
Journal:  Diabetes Metab Syndr       Date:  2020-05-05

Review 4.  COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.

Authors:  David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2020-08-20

5.  Geospatial Analysis of Persons with Movement Disorders Living in Underserved Regions.

Authors:  Alaina Giacobbe; Ka Loong Kelvin Au; Oliver T Nguyen; Kathryn Moore; Emily Dinh; Adolfo Ramirez-Zamora; Michael S Okun; Leonardo Almeida
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2021-08-20

Review 6.  COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?

Authors:  Luigi Ferini-Strambi; Maria Salsone
Journal:  J Neurol       Date:  2020-07-21       Impact factor: 4.849

7.  Impact of Coronavirus Disease 2019 Pandemic on Cognition in Parkinson's Disease.

Authors:  Giovanni Palermo; Luca Tommasini; Filippo Baldacci; Eleonora Del Prete; Gabriele Siciliano; Roberto Ceravolo
Journal:  Mov Disord       Date:  2020-09-08       Impact factor: 9.698

8.  Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross-Sectional Survey of 568 Spanish Patients.

Authors:  Diego Santos-García; Mila Oreiro; Patricia Pérez; Gemma Fanjul; Jose Manuel Paz González; María José Feal Painceiras; Carlos Cores Bartolomé; Lorena Valdés Aymerich; Carlos García Sancho; Maria Del Mar Castellanos Rodrigo
Journal:  Mov Disord       Date:  2020-09-22       Impact factor: 9.698
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.